跳至主要内容
临床试验/IRCT20220513054837N1
IRCT20220513054837N1招募中3 期

Evaluation of the efficacy of curcuma drug in comparison with meloxicam on pain relief and functional improvement of patients with knee osteoarthritis

Shiraz University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40 years 至 60 years(—)
性别
All

入选标准

  • completing and signing a consent form
  • having symptoms of knee osteoarthritis in at least one recent month
  • age between 40 and 60
  • lack of the presence of any other disease around the affected limb

排除标准

  • having diabetes
  • having diseases such as Rheumatism, gout, collagen vascular and lupus
  • having accompanying radiculopathy
  • history of trauma, fracture and injury to the affected joint, nerve damage and neuropathies
  • history of knee replacement on the affected side
  • history of allergies to drugs used in the study
  • history of significant heart, kidney, liver and lung disorders
  • pregnant and lactating women
  • BMI above 42
  • having brucellosis
  • history of injection in the affected joint or in addition in the last 3 months
  • inability to communicating and completing questionnaires
  • patients taking anticoagulants
  • cancer patients
  • history or gastrointestinal disorders and stomach problems
  • consuming warfarin and ticlopidine and aspirin
  • uncontrolled hypertension
  • very severe osteoarthritis of the knee based on radiology

研究者

相似试验